Attached files

file filename
8-K - FORM 8-K - CRANE CO /DE/d8k.htm
EX-99.1 - EARNINGS PRESS RELEASE - CRANE CO /DE/dex991.htm

Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

 

     Three Months Ended
June 30,
   

Six Months Ended

June 30,

 
     2011     2010     2011     2010  

Net Sales:

        

Aerospace & Electronics

   $ 171,538      $ 139,299      $ 333,474      $ 272,944   

Engineered Materials

     60,101        58,646        121,933        112,401   

Merchandising Systems

     94,010        74,527        188,888        144,698   

Fluid Handling

     288,965        254,587        553,107        502,376   

Controls

     29,159        25,755        57,391        50,686   
                                

Total Net Sales

   $ 643,773      $ 552,814      $ 1,254,793      $ 1,083,105   
                                

Operating Profit (Loss):

        

Aerospace & Electronics

   $ 37,157      $ 26,215      $ 71,199      $ 50,704   

Engineered Materials

     9,130        10,172        19,273        18,712   

Merchandising Systems

     7,114        8,110        11,787        13,079   

Fluid Handling

     36,943        32,152        72,396        60,141   

Controls

     3,717        825        6,828        951   

Corporate

     (14,118     (12,170     (28,680     (25,003
                                

Total Operating Profit

     79,943        65,304        152,803        118,584   

Interest Income

     389        236        679        461   

Interest Expense

     (6,429     (6,657     (13,051     (13,383

Miscellaneous- Net

     (290     (604     3,335     (625
                                

Income Before Income Taxes

     73,613        58,279        143,766        105,037   

Provision for Income Taxes

     23,076        18,116        44,851        31,690   
                                

Net income before allocations to noncontrolling interests

     50,537        40,163        98,915        73,347   

Less: Noncontrolling interest in subsidiaries’ earnings

     100        122        11        72   
                                

Net income attributable to common shareholders

   $ 50,437      $ 40,041      $ 98,904      $ 73,275   
                                

Share Data:

        

Earnings per Diluted Share

   $ 0.85      $ 0.67      $ 1.66      $ 1.23   
                                

Average Diluted Shares Outstanding

     59,348        59,894        59,457        59,716   

Average Basic Shares Outstanding

     58,173        58,909        58,259        58,777   

Supplemental Data:

        

Cost of Sales

   $ 423,041      $ 361,779      $ 820,891      $ 714,050   

Selling, General & Administrative

     140,789        125,731        281,099        250,471   

Depreciation and Amortization **

     15,853        15,408        31,627        29,845   

Stock-Based Compensation Expense

     3,771        3,172        7,274        6,344   

 

* Primarily related to the sale of a building and the divestiture of a small product line in the three months ended March 31, 2011.
** Amount included within cost of sales and selling, general & administrative costs.


CRANE CO.

Condensed Balance Sheets

(in thousands)

 

     June 30,
2011
     December 31,
2010
 

ASSETS

     

Current Assets

     

Cash and Cash Equivalents

   $ 231,365       $ 272,941   

Accounts Receivable, net

     377,948         301,918   

Current Insurance Receivable - Asbestos

     33,000         33,000   

Inventories, net

     362,113         319,077   

Other Current Assets

     67,442         61,725   
                 

Total Current Assets

     1,071,868         988,661   

Property, Plant and Equipment, net

     284,101         280,746   

Long-Term Insurance Receivable - Asbestos

     167,412         180,689   

Other Assets

     422,438         446,316   

Goodwill

     824,318         810,285   
                 

Total Assets

   $ 2,770,137       $ 2,706,697   
                 

LIABILITIES AND EQUITY

     

Current Liabilities

     

Notes Payable and Current Maturities of Long-Term Debt

   $ 464       $ 984   

Accounts Payable

     180,216         157,051   

Current Asbestos Liability

     100,000         100,000   

Accrued Liabilities

     221,972         229,462   

Income Taxes

     18,882         11,057   
                 

Total Current Liabilities

     521,534         498,554   

Long-Term Debt

     398,825         398,736   

Long-Term Deferred Tax Liability

     50,224         48,852   

Long-Term Asbestos Liability

     570,768         619,666   

Other Liabilities

     139,521         147,859   

Total Equity

     1,089,265         993,030   
                 

Total Liabilities and Equity

   $ 2,770,137       $ 2,706,697   
                 


CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

 

     Three Months Ended
June 30,
   

Six Months Ended
June 30,

 
     2011     2010     2011     2010  

Operating Activities:

        

Net income attributable to common shareholders

   $ 50,437      $ 40,041      $ 98,904      $ 73,275   

Noncontrolling interest in subsidiaries’ earnings

     100        122        11        72   
                                

Net income before allocations to noncontrolling interests

     50,537        40,163        98,915        73,347   

Gain on divestiture

     —          —          (4,258     —     

Depreciation and amortization

     15,853        15,408        31,627        29,845   

Stock-based compensation expense

     3,771        3,172        7,274        6,344   

Defined benefit plans and postretirement expense

     843        3,775        3,592        6,150   

Deferred income taxes

     6,627        6,538        13,520        13,220   

Cash provided by (used for) operating working capital

     (18,141     11,041        (85,391     (20,646

Defined benefit plans and postretirement contributions

     (5,579     (5,213     (10,358     (6,289

Environmental payments, net of reimbursements

     (1,541     (3,117     (6,134     (6,317

Other

     1,895        (8,321     2,037        (4,265
                                

Subtotal

     54,265        63,446        50,824        91,389   

Asbestos related payments, net of insurance recoveries

     (22,896     (16,360     (35,621     (27,485
                                

Total provided by operating activities

     31,369        47,086        15,203        63,904   
                                

Investing Activities:

        

Capital expenditures

     (10,144     (4,271     (18,282     (8,390

Proceeds from disposition of capital assets

     (23     42        4,530        42   

Payment for acquisition, net of cash acquired

     —          —          —          (51,167

Proceeds from divestiture

     —          —          1,000        —     
                                

Total used for investing activities

     (10,167     (4,229     (12,752     (59,515
                                

Financing Activities:

        

Dividends paid

     (13,385     (11,815     (26,859     (23,558

Reacquisition of shares on open market

     (20,000     (9,990     (49,999     (9,990

Stock options exercised - net of shares reacquired

     4,472        7,675        17,024        12,389   

Excess tax benefit from stock-based compensation

     1,407        578        5,359        969   

Change in short-term debt

     (454     (87     (530     (3,133
                                

Total used for financing activities

     (27,960     (13,639     (55,005     (23,323
                                

Effect of exchange rate on cash and cash equivalents

     4,961        (13,273     10,978        (18,251
                                

Increase (decrease) in cash and cash equivalents

     (1,797     15,945        (41,576     (37,185

Cash and cash equivalents at beginning of period

     233,162        319,584        272,941        372,714   
                                

Cash and cash equivalents at end of period

   $ 231,365      $ 335,529      $ 231,365      $ 335,529   
                                


CRANE CO.

Order Backlog

(in thousands)

 

     June 30,     March 31,     December 31,     September 30,      June 30,  
     2011     2011     2010     2010      2010  

Aerospace & Electronics

   $ 431,799      $ 454,559      $ 431,467      $ 401,585       $ 394,554   

Engineered Materials

     13,087        13,826        11,831        11,367         12,496   

Merchandising Systems

     26,898     25,008     30,170     18,044         20,346   

Fluid Handling

     323,045        305,255        271,825        266,578         257,840   

Controls

     30,323        24,015        22,354        27,575         28,711   
                                         

Total Backlog

   $ 825,152      $ 822,663      $ 767,647      $ 725,149       $ 713,947   
                                         

 

* Includes Order Backlog of $6.2 million at June 30, 2011, $5.3 million at March 31, 2011 and $8.4 million at December 31, 2010 pertaining to the 2010 acquisition of Money Controls.


CRANE CO.

Non-GAAP Financial Measures

(in thousands)

 

     Three Months Ended     Six Months Ended  
     June 30,     June 30,  
     2011     2010     2011     2010  
CASH FLOW ITEMS         

Cash Provided from Operating Activities before Asbestos - Related Payments

   $ 54,265      $ 63,446      $ 50,824      $ 91,389   

Asbestos Related Payments, Net of Insurance Recoveries

     (22,896     (16,360     (35,621     (27,485
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash Provided from Operating Activities

     31,369        47,086        15,203        63,904   

Less: Capital Expenditures

     (10,144     (4,271     (18,282     (8,390
  

 

 

   

 

 

   

 

 

   

 

 

 

Free Cash Flow

   $ 21,225      $ 42,815      $ (3,079   $ 55,514   
  

 

 

   

 

 

   

 

 

   

 

 

 

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company’s performance.

In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate liquidity from its operating activities. The measure of Free Cash Flow does not take into consideration certain other non-discretionary cash requirements such as, for example, mandatory principal payments on the Company’s long-term debt. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.

Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in the context of the definitions of the elements of such measures we provide and in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.